The lesions caused by excess oral pyridoxine hydrochloride (150 mg/kg body weight/day) and clioquinol (200 mg/kg body weight/day), given individually and in combination to adult Beagle dogs, were evaluated. The experimental period was 100 to 112 days, except that four dogs in each of the clioquinol and combined-treatment groups were killed early because of severe debilitation or neurologic disease, and one dog given both compounds died on the third day of compound administration.
pyridoxine hydrochloride and clioquinol had a combination of the lesions in dogs given pyridoxine or clioquinol individually. Several dogs given clioquinol or pyridoxine plus clioquinol had extraneural lesions, including myocardial degeneration and thyroidal alterations.
Clioquinol was used widely to treat amebic and non-specific diarrhea in man, and also was used in animals prior to its implication as a possible agent in the distinctive neurologic disease of man, subacute myelo-optico-neuropathy [7] . Degenerative changes in the dorsal funiculus of the spinal cord and in the optic nerves resembling the lesions of subacute myelo-optico-neuropathy were produced in dogs given high dosages of clioquinol for prolonged periods [4, 8, 18, 19, 20, 23] . Patients with subacute myelo-optico-neuropathy typically had degenerative changes of peripheral nerves [ 161 and, although degenerative peripheral nerve lesions were described in some clioquinol toxicity studies [ 19, 201, other studies found the clioquinol-induced lesions to be limited to the central nervous system [4, 8, 231 .
Toxicologic studies of excess pyridoxine have been limited, possibly because of previous lack of practical significance. In early studies with rats and dogs done shortly after the vitamin was synthesized, it was found that a massive single or divided dose of pyridoxine caused degeneration in the dorsal funiculus of the spinal cord, dorsal spinal roots, spinal ganglia and the peripheral nerves [ 11. Recent interest in megavitamin therapy has resulted in the use of high doses of pyridoxine in multiple vitamins and, therapeutically, for the treatment of a variety of conditions, including neurologic disease. In a recent study, degenerative changes of the central nervous system were limited to the dorsal funiculus in dogs given 200 mg/kg body weight/day of pyridoxine hydrochloride for an average of 107 days [14] . The peripheral nervous system, however, was not examined.
This study was undertaken to characterize further and to compare histologic aspects of the individual subacute neurotoxicities of clioquinol and pyridoxine and the potential toxicity of both compounds given in combination.
Materials and Methods
Twenty-two male and 25 female adult Beagle dogs (Marshall Research Laboratories, Inc., North Rose, N.Y.) were allocated to four groups after an acclimatization period of at least two months. Ten dogs given pyridoxine hydrochloride (Roche Chemical Division, Hoffman-LaRoche Inc., Nutley, N.J.) were introduced to the compound gradually with a dose of 50 mg/kg body weight/day for the first week, 100 mg/kg body weight/day for the second week, and 150 mg/kg body weight/day from the 15th day to the termination of the experiment, 100 to 112 days. Thirteen dogs received 200 mg/kg body weight/day of clioquinol (Ciba-Geigy, Summit, N.J.). Thirteen dogs were given the same doses of both pyridoxine HC1 and clioquinol as given to dogs that received only pyridoxine HC1 or clioquinol. The compounds were given orally in gelatin capsules prior to feeding. Dosages were adjusted weekly according to body weights. Eleven dogs served as controls. Four clioquinol-treated dogs were killed during the experimental period, two because of severe neurologic disease (one dog each on days 5 1 and 79). One dog given both compounds was found comatose and died on the morning of the third day. Four other dogs given both pyridoxine HC1 and clioquinol were killed during the experimental period because of neurologic disease and severe debilitation. Clinical and clinicopathologic data were presented in a companion paper [5] .
All dogs except the one that died on the third day were anesthetized and perfused intravascularly with fixative solutions, either 10% neutral buffered formalin or a phosphatebuffered mixture of 2% glutaraldehyde and 2% paraformaldehyde. Tissues for histologic examination were stored in 10% neutral buffered formalin. Hematoxylin and eosin (HE)stained paraffin coronal sections of the brain were examined at the following sites: thalamus; posterior commissure including posterior optic tracts and lateral geniculate nuclei; the rostra1 colliculus; the trigeminal nerve including the cerebellum; and the nucleus gracilis. HE-stained sections of the spinal cord were examined at four cervicospinal levels (Cl, Cz, C4, and CG), one thoracospinal level (TI), and one lumbospinal level (L4). Left and right spinal ganglia and spinal roots were examined at TI and Lq. Cross and longitudinal HE-stained sections of the following nerves were examined: optic, sciatic, tibial, common peroneal, and superficial peroneal. Selected paraffin sections of nerve tissue were stained by Kluver-Barrera [ 121, Bodian-luxol fast blue [12] , and Gallocyanin [15] methods. In addition, sections of the following tissues were examined: lung, liver, spleen, kidney, heart, pancreas, small intestine (duodenum), stomach (fundus), thyroid, adrenal, gastrocnemius muscle (lateral head), eyes, and all gross lesions.
Results
The gross lesions in the nervous systems of treated dogs in each group consisted of an abnormal opaque whiteness in the dorsal funiculus, in contrast to a more translucent whiteness in lateral and ventral funiculi of these dogs and all spinal cord funiculi of control dogs ( fig. 1 ). In each group, dogs with the most severe lesions had this uniform change in the dorsal funiculus. In one severely affected clioquinoltreated dog, a uniform opaque whiteness involved the dorsal funiculus at C4, and similarly altered small symmetrical foci were found in the dorsal aspects of the lateral funiculi (in the area of the spinocerebellar tract). The mildest change in clioquinol- treated dogs, in the cervical spinal cord, was a well-demarcated symmetrical wedgeshaped area of opaque whiteness involving the fasciculus gracilis. A moderate lesion in dogs given pyridoxine or pyridoxine plus clioquinol was a pronounced opaque whiteness in the central portion (primarily the fasciculus gracilis) of the dorsal funiculus, with little or no change in the dorsal funiculus adjacent to the grey matter.
Histologic examination showed degenerative lesions of varied severity, and limited to anatomic areas specific for each compound, in the nervous systems of all dogs given pyridoxine, 1 1 of 13 given clioquinol and 12 of 13 given pyridoxine plus clioquinol (table I) . Two clioquinol-treated dogs killed early because of pancreatitis and the dog that died on the third day of the experimental period were the only treated dogs without histologic lesions in the central nervous system. Dogs given pyridoxine had prominent lesions in the central nervous system, limited to the dorsal funiculus, the trigeminal nerve fibers and the spinal tracts of the trigeminal nerves ( fig. 2 ). In these areas, the number of axons was reduced and the myelin was irregular and fragmented. The amount of myelin, as determined by Kluver-Barrera stain, was mildly or moderately reduced. Vacuoles, frequently containing debris, gave the affected white tracts a "spongy" appearance ( fig. 3 ). The severity of the lesions in the rostral dorsal funiculi varied considerably among dogs, from minimal to marked; an estimated 70% to 80% of the nerve fibers were affected in the most severe lesions. Astrocytes were prominent because of increased size and number. Phagocytic cells were found occasionally in areas of degeneration.
The lesions in pyridoxine-treated dogs were slightly more severe in the rostral aspects of the dorsal funiculus than in the caudal aspects. The lateral funiculi, ventral funiculus and gray matter of all segments were histologically normal. Degenerative changes similar to those in the dorsal funiculus were present in the nerve fibers of the dorsal spinal roots and some fascicles of peripheral nerves ( fig. 4) , but the ventral spinal roots were not affected. The lesions were characterized by loss of axons and by demyelination with development of vacuoles and myelin elipsoids. The lesions were generally of moderate severity in the distal aspects of the peripheral nerves and were minimal to mild in the dorsal spinal roots. The dorsal roots were normal in several dogs, although prominent lesions occurred in the dorsal funiculus. Spinal ganglia had either no lesions or minimal degenerative changes that consisted of occasional nodules of Nageotte and a few neurons with central chromatolysis and peripheralization of nuclei ( fig. 5 ).
Neurologic lesions in dogs given clioquinol were limited to the central nervous system. Dogs with the mildest lesions had degenerative changes confined to a wedgeshaped area in the rostral dorsal funiculus, involving all or part of the fasciculus gracilis. The entire gracilis and cuneatus fasciculi were involved in the most severely affected dogs ( fig. 6 ). The rostral regions of the dorsal funiculi were much more severely affected than the caudal region. Dogs with severe lesions in the dorsal funiculi had minimal to mild degenerative changes in the anterior regions of the lateral funiculi, particularly in the dorsal spinocerebellar tracts. The caudal aspects of the spinal cord had minimal to mild degenerative changes in the area of the corticospinal tracts.
Of the dogs given clioquinol, .seven of nine that completed the study period and two of four killed early had degenerative changes in the optic nerves (fig. 7) . The severity of the optic nerve lesions varied considerably among clioquinol-treated dogs, but generally paralleled that in the rostral fasciculus gracilis in the same dog. The lesions were more severe in the optic tracts than in the retrobulbar optic nerve. The degenerative changes in the white tracts of the clioquinol-treated dogs were similar to those in pyridoxine-treated dogs, but the anatomic distribution differed. Dogs given pyridoxine plus clioquinol had histologic alterations in anatomic sites affected by both pyridoxine and clioquinol individually. These dogs had degenerative changes in both the optic nerves and in some fascicles of peripheral nerves. The degenerative changes in the anterior dorsal funiculus of these dogs were slightly more severe than in dogs given the individual compounds, but in areas more representative of specific compound effects, such as the optic and peripheral nerves, the lesions were either similar or less severe.
Seven of 13 dogs given clioquinol and 3 of 13 dogs given both pyridoxine and clioquinol had mild to moderate thyroidal alterations. In these thyroids the colloid was pale, depleted and clumped, and cells or cell debris occurred within the thyroidal follicles. The thyroidal follicles were small and were lined by columnar epithelial cells ( fig. 8) .
Foci of myocardial degeneration occurred in 6 of 13 dogs given clioquinol and 3 of 13 dogs given both pyridoxine and clioquinol. The lesions consisted of small foci of myocardial fibrosis containing a few macrophages, some with pigmented cyto- plasmic debris ( fig. 9 ). In one clioquinol-treated dog (killed early because of pancreatitis), moderate myocardial fibrosis and necrosis was accompanied by thrombosis of some medium-sized blood vessels and sharply delineated areas of acute myocardial infarction. The combination-treated dog that died on the third day had multifocal myocardial necrosis. Two dogs that were killed early had severe, acute diffuse necrotizing and suppurative pancreatitis and mild peritonitis.
Discussion
Prolonged oral administration of excess pyridoxine caused degeneration in areas of the nervous system in which the processes of the spinal and trigeminal ganglia neurons are located (the dorsal funiculus, trigeminal nerve fibers and the spinal tract of the trigeminal nerve, the dorsal spinal roots and some fascicles of peripheral nerves), and minimal degeneration of neurons in the spinal ganglia. In earlier studies of acute pyridoxine toxicity in the dog and the rat, there were lesions with a distribution similar to that in our dogs, although in those studies degenerative changes in neurons of the spinal ganglia apparently were more severe than in our dogs [ 11. A recent report of subacute toxicity of excess pyridoxine in Beagle dogs described degenerative changes in the central nervous system, limited to the dorsal funiculus of the spinal cord, but no mention was made of lesions in the trigeminal nerve fibers in the brain stem, and the peripheral nervous system was not examined [14] .
Our study confirms reports that the lesions of subacute clioquinol toxicity in Beagle dogs were limited to the central nervous system [4, 8, 231 . Both pyridoxine and clioquinol caused severe lesions in the dorsal funiculus, but the neurologic disease caused by these compounds can be distinguished in that clioquinol-induced lesions were restricted to the central nervous system, primarily in the distal aspects of the nerve fibers of the dorsal funiculus of the spinal cord and in the optic nerves, and the pyridoxine-induced lesions occurred in both the central and peripheral nervous system, but were limited to processes of neurons located in the spinal and trigeminal ganglia.
The combination of pyridoxine and clioquinol produced lesions in the dorsal funiculus more severe than those caused by either the pyridoxine or clioquinol treatments individually. The lesions in the optic nerves, however, were less severe than those in dogs given only clioquinol. This difference may have resulted from decreased absorption of clioquinol in the combination-treated dogs. These dogs had more severe anorexia and loss of body weight than dogs given only one compound, and it is known that clioquinol absorption is reduced in starved dogs [ 1 11.
Myocardial lesions occurred in some of our dogs given clioquinol, and such lesions as myocardial necrosis have been described in other studies of experimental or spontaneous acute clioquinol toxicity [9, 10, 1 11. We are not aware of previous reports of myocardial fibrosis like that in several of our dogs given clioquinol or clioquinol and pyridoxine. The fibrosis was considered the healing phase of myocardial necrosis that occurred earlier in the experimental period.
Approximately 37% by weight of clioquinol is iodine, and our clioquinol-treated dogs were exposed to increased concentrations of iodine with the extent of exposure depending on the quantity of clioquinol absorbed and the quantity of iodine separated from clioquinol. Goiter resulting from excess dietary iodine has been reported as a naturally occurring disease in man [13, 171 and in young horses [2] , and has been induced experimentally in mice [6] , chickens [21] , and guinea pigs [3] . In the thyroid glands of guinea pigs given excess iodine, the colloid was depleted and the follicular epithelium was columnar. Alterations, such as exfoliation of the epithelial cells into the follicular lumen, have been seen in people given excess iodine [22] . Mild to moderate thyroidal alterations in some of our dogs resembled those described in people and animals given excess iodine. Other studies of clioquinol toxicity have not described lesions in the thyroid. More specific studies than reported here would be required to determine the potential of clioquinol for thyroid toxicity. Previous reports of clioquinol toxicity have not described pancreatitis, and the significance of pancreatitis in two treated dogs of this study remains unknown.
